Watch Ticker

Soligenix, Inc. Common Stock

Go to Soligenix, Inc. Common Stock Website

$3.14

0.40 (14.60%)

Live

Previous Close

$3.11

Day Range

$3.01 - $4.325

Previous Day Range

$2.39 - $2.91

Market Cap

$8.9 million USD

Day Vol.

49.1 million

Previous Day Vol.

7.8 million

Currency

USD

Primary Exchange

Nasdaq

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Non-Hodgkin’s Lymphoma Market Forecast to Surge with Growing Adoption of Targeted and Cell-Based Therapies | DelveInsight

The non-Hodgkin's lymphoma market is expected to grow significantly between 2025-2034, driven by increasing incidence, advancements in targeted therapies, emerging treatments, and improved early detection efforts.

Related tickers: SNGX, IPHA, NRIX, MRK.

Read Full Article

Delveinsight - Cutaneous T-cell Lymphoma Market Anticipates Impressive Growth Trajectory at a CAGR of 7.1% During the Study Period (2020–2034) | DelveInsight

The cutaneous T-cell lymphoma market is expected to grow at a 7.1% CAGR from 2020-2034, driven by research advancements, increasing prevalence, and emerging therapies targeting this rare lymphoma.

Related tickers: SNGX, IPHA.

Read Full Article

Trending Tickers

Please sign in to view